Fig. 4From: Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains frameworkSummary by year indicating percentage of participants who were concerned about and/or who specifically mentioned maternal and/or neonatal/infant adverse effects of antenatal magnesium sulphateBack to article page